These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2593531)

  • 1. [The role of middle molecules in the occurrence of a hyperthermic reaction during the reinfusion of ascitic fluid in patients with liver cirrhosis].
    Korotkiĭ VN; Pokrasen NM; Gaevskaia VA; Liakhov NP
    Klin Khir (1962); 1989; (9):62. PubMed ID: 2593531
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D; Paquet KJ; Kuhn R
    Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Personal experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis].
    Cervinka J; Kordac V; Benes R
    Cas Lek Cesk; 1983 Mar; 122(10):302-5. PubMed ID: 6839336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our 2-year experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis with emphasis on the hemodynamic effects of the renin-angiotensin-aldosterone system].
    Cervinka J; Benes R; Kordac V; Horký K
    Cas Lek Cesk; 1984 Apr; 123(16):482-4. PubMed ID: 6733746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Water-electrolyte metabolism in liver cirrhosis. Physiopathological and therapeutic aspects of reinfusion of concentrated ascitic fluid].
    Borghetti A; Fiaccadori F; Bruschi G; Coruzzi P; Guariglia A; Ghinelli F; Mutti A; Pasetti GC; Perinotto P; Novarini A
    Minerva Med; 1978 Jan; 69(1):53-66. PubMed ID: 628514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drying of cirrhotic ascites by continuous intravenous reinjection of concentrated ascitic fluid].
    Lévy VG; Hecht Y; Georgacopoulos H; Hadchouel P; Touboul JP; Sausse A; Granger A; Stern A; Caroli J
    Ann Med Interne (Paris); 1971 Nov; 122(11):1075-85. PubMed ID: 5150308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Method of reinfusing ascitic fluid].
    Sukhorukov VP; Biteev VKh; Moiseev NI
    Vestn Khir Im I I Grek; 1980 Feb; 124(2):63-5. PubMed ID: 7368510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reinfusion of concentrated ascitic fluid. Hemostatic changes produced in the patients].
    Mate Jiménez J; Pajares García JM; García Gravalos R; Cantero Perona J
    Rev Clin Esp; 1979 Feb; 152(4):295-8. PubMed ID: 451306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acid-base modifications induced by treatment with concentration-reinfusion of ascitis fluid in cyrrhosis (author's transl)].
    Novarini A; Guariglia A; Bruschi G; Borghi L; Canali M; Ghinelli F; Pasetti GC; Perinotto P
    Ateneo Parmense Acta Biomed; 1976; 47(1):5-13. PubMed ID: 1016272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemocoagulation status in reinfusion of ascitic fluid in patients with liver cirrhosis].
    Stibor J; Cieslar P; Cervinka J; Kordac V
    Cas Lek Cesk; 1985 Jan; 124(2):50-2. PubMed ID: 3978679
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reinfusion of ascitic fluid in the treatment of ascites in patients with liver cirrhosis].
    Zhuravlev VA; Sukhorukov VP; Shishkin BA
    Sov Med; 1983; (2):95-7. PubMed ID: 6857357
    [No Abstract]   [Full Text] [Related]  

  • 12. [The reinfusion of ascitic fluid into patients with liver cirrhosis and ascites resistant to drug treatment].
    Kotsev I; Bozhanin D; Martev P; Deliĭski M; Baĭcheva M
    Vutr Boles; 1989; 28(4):93-6. PubMed ID: 2596115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Zinc content of the ascitic fluid caused by malignant ovarian neoplasms and liver cirrhosis].
    Stefanini U; Belgeri R; Ferruti M
    Ann Ostet Ginecol Med Perinat; 1967 Apr; 89(4):273-7. PubMed ID: 5602891
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.
    Tarao K; So K; Moroi T; Ikeuchi T; Suyama T
    Gastroenterology; 1977 Sep; 73(3):539-42. PubMed ID: 892353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of alpha-fetoprotein in the blood and ascitic fluid of cirrhotic patients].
    Reding P; Burette A; Thys O
    Nouv Presse Med; 1981 Feb; 10(7):516. PubMed ID: 6164979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Concentration and reinfusion of ascitic fluid in liver cirrhosis].
    Mian G; Triolo L; Magris D; de Savorgnani MN; G'Agnolo B
    Minerva Med; 1979 Sep; 70(42):2869-72. PubMed ID: 492554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of hemolysates test of ascitic fluid in late stage of schistosomiasis and cirrhosis of liver (author's transl)].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1980 May; 19(3):192-5. PubMed ID: 7227053
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ascites reinfusion in liver cirrhosis (first experiences with the Rhodiascit apparatus) (author's transl)].
    Kreiter H; Albert FW; Helb E
    Med Klin; 1974 Apr; 69(16):687-93. PubMed ID: 4837398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peritoneal diffusion of gentamicin in the ascitic cirrhotic].
    Bars L; Hecht Y; Beaugrand M; Ferrier JP; Hornstein M
    Nouv Presse Med; 1979 Feb; 8(8):614. PubMed ID: 461180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative characteristics of the lipid composition of lipoproteins of the blood plasma and ascitic fluid in liver cirrhosis].
    Kosukhin AB; Riudiger PE; Akhmetova BS; Andreev GN
    Patol Fiziol Eksp Ter; 1989; (2):13-7. PubMed ID: 2755715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.